Macrocyclic proline derived hcv serine protease inhibitors
US-2020270303-A1 · Aug 27, 2020 · US
and Pro-amino acid; Derivatives thereof
and Pro-amino acid; Derivatives thereof · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K5/0823 |
| Official title | {and Pro-amino acid; Derivatives thereof} |
| Display label | and Pro-amino acid; Derivatives thereof |
| Total patents | 105 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 12 |
| 2016 | 9 |
| 2017 | 14 |
| 2018 | 11 |
| 2019 | 11 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 9 |
| 2024 | 14 |
| 2025 | 3 |
| 2026 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Peptides and methods and uses thereof for modulating anaphase promoting complex (apc) activity
US-2020123558-A1 · Apr 23, 2020 · US
CXCR antagonistic peptides and uses thereof
US-10548942-B2 · Feb 4, 2020 · US
Inhibitors for protein n-terminal methyltransferase and uses thereof
US-2019352338-A1 · Nov 21, 2019 · US
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
US-2019269803-A1 · Sep 5, 2019 · US
Macrocyclic proline derived hcv serine protease inhibitors
US-2019263860-A1 · Aug 29, 2019 · US
Anti-Inflammatory Peptides and Composition Comprising the Same
US-2019192638-A1 · Jun 27, 2019 · US
Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
US-10323062-B2 · Jun 18, 2019 · US
Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
US-10308681-B2 · Jun 4, 2019 · US
Proteasome inhibitors
US-2019161516-A1 · May 30, 2019 · US
Ndma receptor modulators and uses thereof
US-2019135862-A1 · May 9, 2019 · US
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
US-10245327-B2 · Apr 2, 2019 · US
Anti-inflammatory peptides and composition comprising the same
US-10206981-B2 · Feb 19, 2019 · US
Anti-Inflammatory Peptides and Composition Comprising the Same
US-2019030137-A1 · Jan 31, 2019 · US
Cxcr antagonistic peptides and uses thereof
US-2018311302-A1 · Nov 1, 2018 · US
Anti-inflammatory peptides and composition comprising the same
US-10039811-B2 · Aug 7, 2018 · US
Chromogenic And Fluorogenic Peptide Substrates For The Detection Of Serine Protease Activity
US-2018215787-A1 · Aug 2, 2018 · US
Method for preventing, improving, or treating inflammatory bowel disease
US-2018208625-A1 · Jul 26, 2018 · US
New hydrogels having a silylated structure, and method for obtaining same
US-2018200408-A1 · Jul 19, 2018 · US
Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
US-2018170961-A1 · Jun 21, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K5/0823?
- CPC C07K5/0823 is the Cooperative Patent Classification code for “and Pro-amino acid; Derivatives thereof.”
- How many patents are filed under CPC C07K5/0823 (and Pro-amino acid; Derivatives thereof)?
- Our database includes 105 publications tagged with this CPC code.
- Is patent activity under CPC C07K5/0823 growing?
- Publication counts under this code: 14 in 2024 vs 3 in 2025 (latest complete years).